|
Conduct a feasibility analysis of any type
|
18.1
|
27.3
|
9.1
|
45.5
|
0
|
|
Consider disease frequency in the general veterinary population
|
36.4
|
54.6
|
0
|
9.1
|
0
|
|
Consider disease frequency Hospital or program-specific caseload
|
45.5
|
45.5
|
4.5
|
4.5
|
0
|
|
Consider existing treatment patterns or guidelines
|
36.4
|
45.5
|
0
|
18.2
|
0
|
|
Consider availability of alternative drugs or treatments
|
18.2
|
54.5
|
0
|
27.3
|
0
|
|
Consider presence of competing trials within the hospital
|
23.8
|
33.3
|
9.5
|
28.6
|
4.8
|
|
Consider presence of competing trials within the geographical region
|
0
|
23.7
|
4.6
|
59.1
|
13.6
|
|
Complete a sample size determination prior to initiating a study
|
27.3
|
40.9
|
9.1
|
18.2
|
4.6
|
|
Use an electronic laboratory note book or study record for clinical data capture
|
9.1
|
18.2
|
13.6
|
54.6
|
4.6
|
|
Complete a formal GCP training program prior to initiation of their first clinical trial
|
13.6
|
0
|
4.6
|
63.6
|
18.2
|
|
Complete a formal RCR training program prior to initiation of their first clinical trial
|
36.4
|
27.3
|
9.1
|
27.3
|
0
|
|
Complete formal budget training program prior to initiation of their first clinical trial
|
0
|
4.6
|
4.6
|
45.5
|
45.5
|
|
Complete a formal grants management training program prior to initiation of their first clinical trial
|
0
|
0
|
4.6
|
54.6
|
41.0
|
|
Read and/or sign a PI agreement dealing with the Institution’s policies procedures and expectations for investigators participating in veterinary clinical research
|
9.1
|
9.1
|
4.6
|
40.9
|
36.4
|
|
Utilize a data safety monitoring committee or similar entity
|
13.6
|
4.6
|
0
|
54.6
|
27.3
|
